oral semaglutide weight loss fda Wegovy approved for obesity management by on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Medical Bulletin] FDA Approves First
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
![oral semaglutide weight loss fda Wegovy approved for obesity management by on December 23, 2025 Formulation: Highdose oral (25 mg daily) previously only available as weekly injections. Indication: Adults with obesity (BMI 30) Medical Bulletin] FDA Approves First](https://image.dongascience.com/Photo/2025/12/17663850386297.jpg)
![oral semaglutide weight loss fda Wegovy approved for obesity management by on December 23, 2025 Formulation: Highdose oral (25 mg daily) previously only available as weekly injections. Indication: Adults with obesity (BMI 30) Medical Bulletin] FDA Approves First](https://c.ndtvimg.com/2025-06/unvvp29_wegovy_625x300_24_June_25.jpeg?im=FeatureCrop,algorithm=dnn,width=640,height=360,output=(format=webp,quality=90))
![oral semaglutide weight loss fda Wegovy approved for obesity management by on December 23, 2025 Formulation: Highdose oral (25 mg daily) previously only available as weekly injections. Indication: Adults with obesity (BMI 30) Medical Bulletin] FDA Approves First](https://cdn.sanity.io/images/0vv8moc6/mhe/74c5395c71ef4aa9cffd275ce3f15dcc016e0869-6000x4000.jpg)



















